Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aline Talhouk

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Pathology|March 3, 2025
Cellular origins of mucinous ovarian carcinomaNicola S Meagher, Martin Köbel, Anthony N Karnezis, et al.
British Journal of Cancer|July 28, 2018
L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profileFelix Kf Kommoss, Anthony N Karnezis, Friedrich Kommoss, et al.
The Journal of Pathology. Clinical Research|November 1, 2017
Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classificationAnthony N Karnezis, Samuel Leung, Jamie Magrill, et al.
Gynecologic Oncology|March 30, 2019
Molecular classification defines outcomes and opportunities in young women with endometrial carcinomaHeidi Britton, Leo Huang, Amy Lum, et al.
Gynecologic Oncology|January 27, 2026
Substratification of mismatch repair deficient endometrial cancers based on mechanism of MMR loss can provide prognostic and predictive refinementAmy Jamieson, Sila Rogan, Allen W Zhang, et al.
The Journal of Molecular Diagnostics : JMD|November 5, 2016
FOXL2 402C>G Mutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult-Type Granulosa Cell TumorAnniina Färkkilä, Melissa K McConechy, Winnie Yang, et al.
Cancer|January 7, 2017
Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancerAline Talhouk, Melissa K McConechy, Samuel Leung, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 31, 2018
Tubo-Ovarian Transitional Cell Carcinoma and High-grade Serous Carcinoma Show Subtly Different Immunohistochemistry ProfilesJamie Magrill, Anthony N Karnezis, Basile Tessier-Cloutier, et al.
The American Journal of Surgical Pathology|January 13, 2017
Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular SubgroupLien N Hoang, Mary A Kinloch, Joyce M Leo, et al.
Gynecologic Oncology|July 17, 2016
Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatmentAline Talhouk, Lien N Hoang, Melissa K McConechy, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Pathology|March 3, 2025
Cellular origins of mucinous ovarian carcinomaNicola S Meagher, Martin Köbel, Anthony N Karnezis, et al.
British Journal of Cancer|July 28, 2018
L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profileFelix Kf Kommoss, Anthony N Karnezis, Friedrich Kommoss, et al.
The Journal of Pathology. Clinical Research|November 1, 2017
Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classificationAnthony N Karnezis, Samuel Leung, Jamie Magrill, et al.
Gynecologic Oncology|March 30, 2019
Molecular classification defines outcomes and opportunities in young women with endometrial carcinomaHeidi Britton, Leo Huang, Amy Lum, et al.
Gynecologic Oncology|January 27, 2026
Substratification of mismatch repair deficient endometrial cancers based on mechanism of MMR loss can provide prognostic and predictive refinementAmy Jamieson, Sila Rogan, Allen W Zhang, et al.
The Journal of Molecular Diagnostics : JMD|November 5, 2016
FOXL2 402C>G Mutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult-Type Granulosa Cell TumorAnniina Färkkilä, Melissa K McConechy, Winnie Yang, et al.
Cancer|January 7, 2017
Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancerAline Talhouk, Melissa K McConechy, Samuel Leung, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 31, 2018
Tubo-Ovarian Transitional Cell Carcinoma and High-grade Serous Carcinoma Show Subtly Different Immunohistochemistry ProfilesJamie Magrill, Anthony N Karnezis, Basile Tessier-Cloutier, et al.
The American Journal of Surgical Pathology|January 13, 2017
Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular SubgroupLien N Hoang, Mary A Kinloch, Joyce M Leo, et al.
Gynecologic Oncology|July 17, 2016
Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatmentAline Talhouk, Lien N Hoang, Melissa K McConechy, et al.
Pageof 10